HEADER HYDROLASE/HYDROLASE INHIBITOR 27-JUL-94 1EPP TITLE ENDOTHIA ASPARTIC PROTEINASE (ENDOTHIAPEPSIN) COMPLEXED WITH PD-130, TITLE 2 693 (MAS PHE LYS+MTF STA MBA) COMPND MOL_ID: 1; COMPND 2 MOLECULE: ENDOTHIAPEPSIN; COMPND 3 CHAIN: E; COMPND 4 EC: 3.4.23.22; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: CRYPHONECTRIA PARASITICA; SOURCE 3 ORGANISM_COMMON: CHESTNUT BLIGHT FUNGUS; SOURCE 4 ORGANISM_TAXID: 5116 KEYWDS HYDROLASE-HYDROLASE INHIBITOR COMPLEX, ACID PROTEINASE EXPDTA X-RAY DIFFRACTION AUTHOR B.A.WALLACE,J.B.COOPER,T.L.BLUNDELL REVDAT 6 29-NOV-17 1EPP 1 HELIX REVDAT 5 13-JUL-11 1EPP 1 VERSN REVDAT 4 25-AUG-09 1EPP 1 SOURCE REVDAT 3 24-FEB-09 1EPP 1 VERSN REVDAT 2 01-APR-03 1EPP 1 JRNL REVDAT 1 20-DEC-94 1EPP 0 JRNL AUTH E.A.LUNNEY,H.W.HAMILTON,J.C.HODGES,J.S.KALTENBRONN, JRNL AUTH 2 J.T.REPINE,M.BADASSO,J.B.COOPER,C.DEALWIS,B.A.WALLACE, JRNL AUTH 3 W.T.LOWTHER JRNL TITL ANALYSES OF LIGAND BINDING IN FIVE ENDOTHIAPEPSIN CRYSTAL JRNL TITL 2 COMPLEXES AND THEIR USE IN THE DESIGN AND EVALUATION OF JRNL TITL 3 NOVEL RENIN INHIBITORS. JRNL REF J.MED.CHEM. V. 36 3809 1993 JRNL REFN ISSN 0022-2623 JRNL PMID 8254610 JRNL DOI 10.1021/JM00076A008 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH D.BAILEY,J.B.COOPER REMARK 1 TITL A STRUCTURAL COMPARISON OF 21 INHIBITOR COMPLEXES OF THE REMARK 1 TITL 2 ASPARTIC PROTEINASE FROM ENDOTHIA PARASITICA REMARK 1 REF TO BE PUBLISHED REMARK 1 REFN REMARK 1 REFERENCE 2 REMARK 1 AUTH T.L.BLUNDELL,J.JENKINS,B.T.SEWELL,L.H.PEARL,J.B.COOPER, REMARK 1 AUTH 2 I.J.TICKLE,B.VEERAPANDIAN,S.P.WOOD REMARK 1 TITL THE 3D STRUCTURE AT 2 ANGSTROMS RESOLUTION OF ENDOTHIAPEPSIN REMARK 1 REF J.MOL.BIOL. V. 211 919 1990 REMARK 1 REFN ISSN 0022-2836 REMARK 2 REMARK 2 RESOLUTION. 1.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : RESTRAIN REMARK 3 AUTHORS : MOSS,DRIESSEN,HANEEF,HOWLIN,HARRIS REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 84.0 REMARK 3 NUMBER OF REFLECTIONS : 17899 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING + TEST SET) : 0.160 REMARK 3 R VALUE (WORKING SET) : NULL REMARK 3 FREE R VALUE : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2389 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 57 REMARK 3 SOLVENT ATOMS : 260 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA REMARK 3 BOND LENGTH (A) : 0.028 ; NULL REMARK 3 ANGLE DISTANCE (A) : 0.043 ; NULL REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : 0.019 ; NULL REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL REMARK 3 REMARK 3 PLANE RESTRAINT (A) : NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : NULL ; NULL REMARK 3 REMARK 3 NON-BONDED CONTACT RESTRAINTS. REMARK 3 SINGLE TORSION (A) : NULL ; NULL REMARK 3 MULTIPLE TORSION (A) : NULL ; NULL REMARK 3 H-BOND (X...Y) (A) : NULL ; NULL REMARK 3 H-BOND (X-H...Y) (A) : NULL ; NULL REMARK 3 REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS. REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL REMARK 3 PLANAR (DEGREES) : NULL ; NULL REMARK 3 STAGGERED (DEGREES) : NULL ; NULL REMARK 3 TRANSVERSE (DEGREES) : NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: THE QUANTITY GIVEN IN THE TEMPERATURE REMARK 3 FACTOR FIELD OF THE *ATOM* AND *HETATM* RECORDS BELOW IS U**2, REMARK 3 WHICH IS THE MEAN-SQUARE AMPLITUDE OF ATOMIC VIBRATION. THE REMARK 3 TEMPERATURE FACTOR, B, CAN BE DERIVED BY THE FOLLOWING RELATION: REMARK 3 B = 8 * (PI)**2 * U**2. REMARK 4 REMARK 4 1EPP COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 100 THE DEPOSITION ID IS D_1000173120. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : NULL REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : NULL REMARK 200 RADIATION SOURCE : NULL REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : NULL REMARK 200 WAVELENGTH OR RANGE (A) : NULL REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : NULL REMARK 200 RESOLUTION RANGE HIGH (A) : NULL REMARK 200 RESOLUTION RANGE LOW (A) : NULL REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : NULL REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 40.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.05 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 37.80000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH E 497 O HOH E 572 1.82 REMARK 500 O HOH E 461 O HOH E 462 1.93 REMARK 500 O HOH E 430 O HOH E 522 2.13 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH E 533 O HOH E 593 1655 0.42 REMARK 500 O HOH E 554 O HOH E 569 2656 1.71 REMARK 500 OG1 THR E 319 O HOH E 583 2555 1.85 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 TRP E 39 N TRP E 39 CA 0.151 REMARK 500 GLY E 52 N GLY E 52 CA 0.127 REMARK 500 GLN E 53 CD GLN E 53 OE1 0.133 REMARK 500 SER E 74 CA SER E 74 CB -0.096 REMARK 500 SER E 201 CB SER E 201 OG 0.079 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO E 23 O - C - N ANGL. DEV. = -10.9 DEGREES REMARK 500 ASP E 30 CB - CG - OD1 ANGL. DEV. = 11.7 DEGREES REMARK 500 ASP E 32 CB - CG - OD1 ANGL. DEV. = 5.9 DEGREES REMARK 500 SER E 43 O - C - N ANGL. DEV. = -12.0 DEGREES REMARK 500 VAL E 50 CA - CB - CG2 ANGL. DEV. = 9.0 DEGREES REMARK 500 GLY E 52 C - N - CA ANGL. DEV. = -16.6 DEGREES REMARK 500 TYR E 56 O - C - N ANGL. DEV. = 11.6 DEGREES REMARK 500 TYR E 75 CB - CG - CD2 ANGL. DEV. = -3.7 DEGREES REMARK 500 SER E 80A N - CA - CB ANGL. DEV. = 9.2 DEGREES REMARK 500 TYR E 85 CB - CG - CD1 ANGL. DEV. = -6.3 DEGREES REMARK 500 VAL E 89 CA - CB - CG2 ANGL. DEV. = 13.1 DEGREES REMARK 500 VAL E 91 CA - CB - CG2 ANGL. DEV. = 13.3 DEGREES REMARK 500 VAL E 107 CA - CB - CG2 ANGL. DEV. = 10.9 DEGREES REMARK 500 LEU E 121 O - C - N ANGL. DEV. = -11.2 DEGREES REMARK 500 LEU E 128 CB - CG - CD2 ANGL. DEV. = 13.1 DEGREES REMARK 500 PRO E 133 C - N - CD ANGL. DEV. = -14.1 DEGREES REMARK 500 PHE E 138 CB - CG - CD2 ANGL. DEV. = -5.9 DEGREES REMARK 500 PHE E 138 CB - CG - CD1 ANGL. DEV. = 7.0 DEGREES REMARK 500 VAL E 150 CA - CB - CG1 ANGL. DEV. = 12.8 DEGREES REMARK 500 PHE E 151 CA - C - O ANGL. DEV. = 14.0 DEGREES REMARK 500 PHE E 151 O - C - N ANGL. DEV. = -12.9 DEGREES REMARK 500 ALA E 159 N - CA - CB ANGL. DEV. = -9.8 DEGREES REMARK 500 TYR E 165 CB - CG - CD2 ANGL. DEV. = -5.1 DEGREES REMARK 500 TYR E 165 CG - CD2 - CE2 ANGL. DEV. = -6.4 DEGREES REMARK 500 PHE E 169 CD1 - CE1 - CZ ANGL. DEV. = -7.7 DEGREES REMARK 500 TYR E 181 CB - CG - CD2 ANGL. DEV. = 5.2 DEGREES REMARK 500 TYR E 181 CB - CG - CD1 ANGL. DEV. = -5.4 DEGREES REMARK 500 ALA E 183 CB - CA - C ANGL. DEV. = -9.2 DEGREES REMARK 500 VAL E 184 CA - CB - CG2 ANGL. DEV. = 9.6 DEGREES REMARK 500 TYR E 197 CG - CD1 - CE1 ANGL. DEV. = -5.4 DEGREES REMARK 500 TYR E 197 CD1 - CE1 - CZ ANGL. DEV. = 6.3 DEGREES REMARK 500 TYR E 222 CB - CG - CD2 ANGL. DEV. = -5.3 DEGREES REMARK 500 ALA E 225 O - C - N ANGL. DEV. = -11.1 DEGREES REMARK 500 TRP E 232 CB - CG - CD2 ANGL. DEV. = 8.1 DEGREES REMARK 500 TRP E 232 CB - CG - CD1 ANGL. DEV. = -9.1 DEGREES REMARK 500 TRP E 232 CE3 - CZ3 - CH2 ANGL. DEV. = 8.1 DEGREES REMARK 500 TRP E 232 CZ3 - CH2 - CZ2 ANGL. DEV. = -8.6 DEGREES REMARK 500 SER E 236 O - C - N ANGL. DEV. = 10.8 DEGREES REMARK 500 VAL E 243 CA - CB - CG2 ANGL. DEV. = 12.1 DEGREES REMARK 500 TYR E 246 CB - CG - CD2 ANGL. DEV. = 4.9 DEGREES REMARK 500 TYR E 246 CB - CG - CD1 ANGL. DEV. = -6.7 DEGREES REMARK 500 PHE E 257 CB - CG - CD2 ANGL. DEV. = 4.6 DEGREES REMARK 500 ARG E 265 NE - CZ - NH2 ANGL. DEV. = -3.8 DEGREES REMARK 500 ILE E 266 O - C - N ANGL. DEV. = 11.6 DEGREES REMARK 500 ASP E 274 CB - CG - OD1 ANGL. DEV. = 6.0 DEGREES REMARK 500 PHE E 275 CB - CG - CD1 ANGL. DEV. = -4.7 DEGREES REMARK 500 PHE E 275 CG - CD2 - CE2 ANGL. DEV. = -7.0 DEGREES REMARK 500 ASP E 304 CB - CG - OD1 ANGL. DEV. = 6.9 DEGREES REMARK 500 VAL E 305 CA - CB - CG1 ANGL. DEV. = 10.2 DEGREES REMARK 500 VAL E 312 CA - CB - CG2 ANGL. DEV. = 13.2 DEGREES REMARK 500 REMARK 500 THIS ENTRY HAS 54 ANGLE DEVIATIONS. REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP E 51 -126.51 -96.28 REMARK 500 REMARK 500 REMARK: NULL REMARK 600 REMARK 600 HETEROGEN REMARK 600 REMARK 600 THE INHIBITOR HAS A K(I) OF 69 NM FOR ENDOTHIAPEPSIN. REMARK 630 REMARK 630 MOLECULE TYPE: PEPTIDE-LIKE INHIBITOR REMARK 630 MOLECULE NAME: N-(DIMETHYLSULFAMOYL)-L-PHENYLALANYL-N-[(1S,2S)-2- REMARK 630 HYDROXY-4-{[(2S)-2-METHYLBUTYL]AMINO}-1-(2-METHYLPROPYL)-4- REMARK 630 OXOBUTYL]-N~6~-(METHYLCARBAMOTHIOYL)-L-LYSINAMIDE REMARK 630 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 630 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 630 REMARK 630 M RES C SSSEQI REMARK 630 1Z1 E 333 REMARK 630 SOURCE: NULL REMARK 630 TAXONOMY: NULL REMARK 630 SUBCOMP: MAS PHE LMF STA DCI REMARK 630 DETAILS: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 E 327 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 E 328 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 1Z1 E 333 REMARK 800 REMARK 800 SITE_IDENTIFIER: CAT REMARK 800 EVIDENCE_CODE: AUTHOR REMARK 800 SITE_DESCRIPTION: CATALYTIC SITE REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1EPQ RELATED DB: PDB REMARK 999 REMARK 999 SEQUENCE REMARK 999 RESIDUES 63A, 80A, 134A, 184A, 203A, 204A, 238A, 282A, 282B, AND REMARK 999 319A IN CHAIN E ARE INSERTIONS RELATIVE TO PORCINE PEPSIN. DBREF 1EPP E -2 326 UNP P11838 CARP_CRYPA 90 419 SEQRES 1 E 330 SER THR GLY SER ALA THR THR THR PRO ILE ASP SER LEU SEQRES 2 E 330 ASP ASP ALA TYR ILE THR PRO VAL GLN ILE GLY THR PRO SEQRES 3 E 330 ALA GLN THR LEU ASN LEU ASP PHE ASP THR GLY SER SER SEQRES 4 E 330 ASP LEU TRP VAL PHE SER SER GLU THR THR ALA SER GLU SEQRES 5 E 330 VAL ASP GLY GLN THR ILE TYR THR PRO SER LYS SER THR SEQRES 6 E 330 THR ALA LYS LEU LEU SER GLY ALA THR TRP SER ILE SER SEQRES 7 E 330 TYR GLY ASP GLY SER SER SER SER GLY ASP VAL TYR THR SEQRES 8 E 330 ASP THR VAL SER VAL GLY GLY LEU THR VAL THR GLY GLN SEQRES 9 E 330 ALA VAL GLU SER ALA LYS LYS VAL SER SER SER PHE THR SEQRES 10 E 330 GLU ASP SER THR ILE ASP GLY LEU LEU GLY LEU ALA PHE SEQRES 11 E 330 SER THR LEU ASN THR VAL SER PRO THR GLN GLN LYS THR SEQRES 12 E 330 PHE PHE ASP ASN ALA LYS ALA SER LEU ASP SER PRO VAL SEQRES 13 E 330 PHE THR ALA ASP LEU GLY TYR HIS ALA PRO GLY THR TYR SEQRES 14 E 330 ASN PHE GLY PHE ILE ASP THR THR ALA TYR THR GLY SER SEQRES 15 E 330 ILE THR TYR THR ALA VAL SER THR LYS GLN GLY PHE TRP SEQRES 16 E 330 GLU TRP THR SER THR GLY TYR ALA VAL GLY SER GLY THR SEQRES 17 E 330 PHE LYS SER THR SER ILE ASP GLY ILE ALA ASP THR GLY SEQRES 18 E 330 THR THR LEU LEU TYR LEU PRO ALA THR VAL VAL SER ALA SEQRES 19 E 330 TYR TRP ALA GLN VAL SER GLY ALA LYS SER SER SER SER SEQRES 20 E 330 VAL GLY GLY TYR VAL PHE PRO CYS SER ALA THR LEU PRO SEQRES 21 E 330 SER PHE THR PHE GLY VAL GLY SER ALA ARG ILE VAL ILE SEQRES 22 E 330 PRO GLY ASP TYR ILE ASP PHE GLY PRO ILE SER THR GLY SEQRES 23 E 330 SER SER SER CYS PHE GLY GLY ILE GLN SER SER ALA GLY SEQRES 24 E 330 ILE GLY ILE ASN ILE PHE GLY ASP VAL ALA LEU LYS ALA SEQRES 25 E 330 ALA PHE VAL VAL PHE ASN GLY ALA THR THR PRO THR LEU SEQRES 26 E 330 GLY PHE ALA SER LYS HET SO4 E 327 5 HET SO4 E 328 5 HET 1Z1 E 333 47 HETNAM SO4 SULFATE ION HETNAM 1Z1 N-(DIMETHYLSULFAMOYL)-L-PHENYLALANYL-N-[(1S,2S)-2- HETNAM 2 1Z1 HYDROXY-4-{[(2S)-2-METHYLBUTYL]AMINO}-1-(2- HETNAM 3 1Z1 METHYLPROPYL)-4-OXOBUTYL]-N~6~-(METHYLCARBAMOTHIOYL)- HETNAM 4 1Z1 L-LYSINAMIDE FORMUL 2 SO4 2(O4 S 2-) FORMUL 4 1Z1 C32 H57 N7 O6 S2 FORMUL 5 HOH *260(H2 O) HELIX 1 H1 THR E 57 SER E 61 1 5 HELIX 2 H2 SER E 108 GLU E 113 1 6 HELIX 3 H3 THR E 137 LYS E 143 1 7 HELIX 4 H4 PRO E 224 GLN E 234 1 11 HELIX 5 H5 GLY E 303 LYS E 308 1 6 SHEET 1 N1 8 THR E -1 ILE E 7 0 SHEET 2 N1 8 ALA E 13 GLY E 21 -1 N ILE E 15 O THR E 5 SHEET 3 N1 8 ALA E 24 THR E 33 -1 N LEU E 29 O THR E 16 SHEET 4 N1 8 ILE E 117 ALA E 124 1 N LEU E 121 O ASP E 30 SHEET 5 N1 8 SER E 36 GLU E 44 -1 N TRP E 39 O LEU E 120 SHEET 6 N1 8 GLN E 99 LYS E 105 1 N ALA E 104 O VAL E 40 SHEET 7 N1 8 GLY E 78 ASP E 87 -1 N ASP E 83 O SER E 103 SHEET 8 N1 8 TRP E 71 GLY E 76 -1 N TRP E 71 O GLY E 82 SHEET 1 C1 8 SER E 178 LYS E 186 0 SHEET 2 C1 8 PHE E 189 THR E 195 -1 N GLU E 191 O SER E 184A SHEET 3 C1 8 ASP E 211 THR E 216 -1 N GLY E 212 O TRP E 192 SHEET 4 C1 8 ILE E 299 PHE E 302 1 N PHE E 302 O ILE E 213 SHEET 5 C1 8 THR E 219 PRO E 224 -1 N TYR E 222 O ILE E 301 SHEET 6 C1 8 SER E 282 SER E 294 1 N GLN E 288 O LEU E 221 SHEET 7 C1 8 GLY E 244 CYS E 250 -1 N PHE E 248 O CYS E 283 SHEET 8 C1 8 ALA E 238 SER E 241 -1 N LYS E 238A O VAL E 247 SHEET 1 N2 4 ALA E 24 ASN E 28 0 SHEET 2 N2 4 PRO E 17 GLY E 21 -1 N ILE E 20 O GLN E 25 SHEET 3 N2 4 VAL E 89 VAL E 91 -1 N SER E 90 O GLN E 19 SHEET 4 N2 4 LEU E 94 VAL E 96 -1 N VAL E 96 O VAL E 89 SHEET 1 C2 4 GLY E 202 LYS E 204 0 SHEET 2 C2 4 GLY E 196 VAL E 199 -1 N TYR E 197 O LYS E 204 SHEET 3 C2 4 SER E 256 VAL E 261 -1 N GLY E 260 O GLY E 196 SHEET 4 C2 4 ALA E 264 ILE E 268 -1 N ILE E 266 O PHE E 259 SHEET 1 NC 6 THR E -1 ILE E 7 0 SHEET 2 NC 6 PRO E 162 THR E 172 -1 N TYR E 165 O ALA E 2 SHEET 3 NC 6 SER E 148 TYR E 157 -1 N ASP E 154 O THR E 164 SHEET 4 NC 6 ALA E 310 GLY E 316 -1 N VAL E 312 O ALA E 153 SHEET 5 NC 6 THR E 319 LYS E 326 -1 N GLY E 322 O VAL E 313 SHEET 6 NC 6 SER E 178 LYS E 186 -1 N THR E 182 O LEU E 321 SSBOND 1 CYS E 250 CYS E 283 1555 1555 2.22 CISPEP 1 THR E 22 PRO E 23 0 -2.35 CISPEP 2 SER E 132 PRO E 133 0 3.74 SITE 1 AC1 5 LYS E 238A SER E 240 SER E 241 SER E 242 SITE 2 AC1 5 HOH E 521 SITE 1 AC2 6 SER E 108 SER E 109 THR E 318 THR E 319 SITE 2 AC2 6 HOH E 459 HOH E 542 SITE 1 AC3 14 ASP E 12 ASP E 30 ASP E 32 GLY E 34 SITE 2 AC3 14 TYR E 75 GLY E 76 ASP E 77 ASP E 114 SITE 3 AC3 14 PHE E 189 ASP E 215 GLY E 217 THR E 218 SITE 4 AC3 14 THR E 219 HOH E 335 SITE 1 CAT 2 ASP E 32 ASP E 215 CRYST1 43.100 75.600 42.900 90.00 97.20 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.023202 0.000000 0.002931 0.00000 SCALE2 0.000000 0.013228 0.000000 0.00000 SCALE3 0.000000 0.000000 0.023495 0.00000